Intravenous lipid emulsion
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Intravenous lipid emulsion, covering 2014-05-26 to 2025-11-28. Get the full timeline:
Most recent: Clinical Trial Update: Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration [Phase 2]